For centuries, pharmacognosy was essential for the identification, quality, purity and -until the end of the 18th century even for the efficacy -of medicinal plants. Since the 19th century, it concentrated on authenticity, purity, quality and the analysis of active substances, was established as an academic branch discipline within pharmacy and continuously developed into a modern, highly sophisticated science. Even though the paradigm in pharmacy changed in the 19th century with the discovery of morphine and concentrated on single substances which could be synthesized fast by the upcoming industry, medicinal plants always remained an important element of the Materia medica and during the last decades medicinal plants continue to be both a sources of remedies and natural products are an inspiration for new medicine. In this research, pharmacognostic skills remain an essential element, both with regards to identity, quality assurance of botanicals (both herbal medicines and supplements) and the discovery and development of new medicines. Over the years the specific pharmacognostical tools have changed dramatically, and most recently DNA-based techniques have become another element of our spectrum of scientific methods
Introduction
Pharmacognosy has accompanied humans for millennia and over centuries developed traditions of evidence-based knowledge in cultures. It addresses both challenges relating to the supply of safe medicines and offers unique opportunities for modern drug discovery. -The term will be used throughout the paper in the literal sense "the knowledge about medicinal drugs" and is not reduced to the definition of the academic discipline since the 19th century.
In this paper, we mainly focus on the history of pharmacognosy in Europe being well aware of the fact that principally similar developments can be observed in many regions and cultures in the world which -metaphorically spoken -open unlimited horizons for research in pharmacognosy and drug discovery. Until the early 19th century, the regnum vegetabile or kingdom of plants was the most important and uncontested source for therapeutic agents in medicine and pharmacy.
As keeping and restoring health is doubtlessly an essential element of survival, it is not surprising that the knowledge about medicinal plants was highly appreciated as the famous botanist Augustin-Pyrame de Candolle (1778-1841) who stated: "Among all kinds of human knowledge, pharmacognosy is the most useful" and in 1909 the celebrate pharmacognosist Alexander Tschirch (1856 Tschirch ( -1939 considered it "eine wahre scientia regia", a real royal science [1] . Yet, the ideas about the character, definition and purpose of pharmacognosy changed over the centuries. While it comprised any knowledge about medicinal plants like identity, origin, habitat, morphology, medicinal properties, ways of application, methods of preparation, and adulterations from ancient times on, in the context of the differentiation of sciences since early modern time, it gradually developed into a science which mainly concentrated on identity, quality and purity. Since early modern age, one of the traditionally central parts of what later would be called pharmacognosy-the efficacy of medicinal plants which was always defined by the referring contemporary theoretical concepts like the Galenic humoral pathology -shifted into pharmacology. However, it has always remained a complex, ambitious science comprising various expertise in many other scientific disciplines and today contributes again significantly to the exploration of the effects and efficacy of medicinal plants.
With the development of the plant chemistry since the 18th century culminating in the isolation of morphine by the German apothecary Friedrich Wilhelm Adam Sertürner (1783-1841), the attention of pharmacy and medicine finally turned to single substances, their derivatives and synthetic molecules which could be produced fast on an industrial level and were thought to be better controllable in dosage, efficacy and side effects. In the progress of this development, many medicinal plants fell into oblivion, were not further investigated or not even studied at all [2, 3, 4 ]. drugs. At the same time, it is an area which has received little attention and in the 21st century few pharmaceutical scientists are trained in this field. As the name indicates it is a practice-centred book and does not strive for incorporating the latest methodological innovations, but for practical usefulness. As another researcher in the field famously stated "Jeder Fortschritt in den Methoden ist auch ein Fortschritt in der Wissenschaft" (Egon Stahl: 'Every progress in methods also is a progress in science'), over the last two hundred years the approaches and methods in this field have changed dramatically and continue to do so [6] .
There have been numerous reviews assessing specific developments in this field of research [e.g. 7, 8, 9] , which has also been covered in a wide range of textbooks [e.g. 10-Trease and Evan's Pharmacognosy,11; 7; 12, as well as, for example, German language textbook like 13, 14] .
During the last decades, the scientific interest has turned again to medicinal plants as research in tradition, compounds and composition might reveal new opportunities for the future challenges and essential medical needs, not only under the aspect of "soft therapeutics" but also as a source of highly effective resources for the treatment of serious diseases with presently unsatisfying therapeutic solutions. Today we have new methods and much more knowledge to explore the composition of plants under the aspect of their efficacy much deeper than ever and can now link this to pharmacological and clinical studies allowing a much better understanding of herbal medicines. In this development, pharmacognosy will be a central and irreplaceable science and cover further essential fields of investigation.
Millennia of experience and tradition -The Scientia Regia
The knowledge about the identity, quality, properties and uses of medicinal developed over thousands of years in a process of evidence-based experience, exchange of expertise and the forming of a complex tradition which nowadays can be explored by the methods and instruments of modern science.
While ancient cultures around the globe had gathered, and adopted knowledge about the heal- [18, 19] . However, Alexander Tschirch's impressive achievements and innovative research approaches did not lead to intense research efforts in exploring the properties and potential therapeutic use of medicinal plants even though pharmacognosy was well established in the academic curriculum of the pharmaceutical branch disciplines in many countries -with the exception of Germany, a fact which was often criticized and discussed [24, 46] . It took decades until his concept of exploring the chemical compounds was intensely developed by researchers like Kurt Mothes (1900 Mothes ( -1983 
There is ample historical evidence that the concentration on the application of single substance in drug discovery and development pushed plants as multi-compound mixtures into the background. This was driven by the expectation that this made it easier to control dosage and efficacy and, most importantly, that such medicines could be produced in large amounts at a low price in the growing pharmaceutical and chemical industry to satisfy the needs. This is exemplified by highly effective substances like the Camptothecin derivatives from Camptotheca acuminata Decne., the vinca alkaloids from Catharanthus roseus (L.) G. Don, or taxanes from Taxus brevifolia Nutt.
The challenges of investigating the complexity of the composition, the efficacy, synergistic effects and the adequate dosages could not be met by the analytical-technical tools of the period. Neither did the state of knowledge in related sciences like biochemistry, pharmacology, biotechnology and genetics research allow a fruitful research on such complex mistures.
With the large number of unsatisfied needs and future challenges in medical therapy, plants as multi-compound mixtures have gained new attention as potential therapeutic agents. With the immense knowledge in many scientific fields accompanied by adequate analyticaltechnical approaches offers unique possibilities to explore the medicinal plants which have been used over centuries again based on empirical evidence and make them available inmodern therapies. This requires -as outlined in the following part -more detailed studies in analytics, efficacy, synergistic efficacts and clinical application are necessary and it is also essential to reconsider the present regulatory framework and its applicability for the registration of phytotherapeutics and plant-based medicines
Pharmacognosy today -analytical and regulatory challenges
This focus on complex mixtures remains a core interest of modern pharmacognosy, and in a very general way it can be divided into two lines of activities, thus expanding and modifying the original focus (see above):
-The identification and authentication of drug substances and the quality of the resulting medicines and the -Search for new medicines, their production and research into understanding their pharmacological (incl. toxicological) effects and their effectiveness.
Clearly the first very much follows the classical definitions as laid out above. These aspects of the field were developed at a moment in history when complex preparations derived from natural sources still were the only source of medicines. Today, a very diverse set of pharmacognostic methods is available, including microscopic [6] , phytochemical [28] and genetic [29] techniques. Here is not the space for specifically reviewing such techniques, but to highlight these changing approaches, and the importance of the regulatory framework in defining best practice. currently not accepted as validated methods, but offer new opportunities and while they may not use the term 'pharmacognosy' these methods all are used with in essence the same objectives as they were defined by Alexander Tschirch and his predecessors -to ascertain the authenticity and quality of the herbal substance and the products derived from it. DNA-barcoding is making an important contribution to understanding not only the quality, but the systematic complexity of the species and its relatives. DNA barcoding uses small and well-defined DNA sequences in the plants' genome as a distinctive characteristic allowing a species' identification. The methodology was, of course, developed in the context of genetic research and in botany plays a key role in plant systematics becoming an important tool not only for specimen identification, but also for significant advances in systematics allowing a much better understanding of the relationship between taxa. In the last years, it has also been embraced as a tool to authenticate botanical drugs at the species level (i.e. it cannot be used to identify a botanical drug but only the taxon it is derived from). Clearly it will allow the identification of genetically distinct material in a botanical drug, but the limitations of the approach are multi-fold. It is one of many techniques used to define the composition and quality of a botanical drug and of extracts derived from it. Obviously, all DNA-based methods also are indirect methods in the sense that they do not allow to identify or even quantify the active metabolites in the plant or its preparations. The most important limitation clearly is that in general it can only be used on unprocessed drug material and not with extracts and after any other process which results in the degradation of the DNA. While opportunities for DNA barcoding with processed materials are actively explored (e.g. amplicon metabarcoding -AMB), methods which can be incorporated into a pharmacopoeia for such materials still will require considerable research and development. The complexity of species and the species concept need to be taken into consideration [e.g. in complex species (aggregates), especially in taxa where apomixis and polyploidy are common]. Consequently, one will always have to rely on a combination of methods.
With regards to drug substances and their quality and analysis and using
In our context it does highlight that all these methods contribute to the cognosis or identification of the pharmacon or the drug substance. As pointed out, among others, by Parveen et al [29] , in general a combination of methods will be needed for the 'successful authentication of botanical ingredients'. There are few drugs for which such a detailed set of analytical techniques is available, and depending on the breadth of definition of a medicinal (and health food) plant for thousands and more species there is a need to develop such pharmacognostical techniques. Clearly, a limit will have to be drawn and this must be based on the relevance of these species in national and international trade networks.
While in this context pharmacognosy remains essentially an analytical science, it is also embedded in the specific regulatory framework of a country or regions. Lack of quality control is common and the resulting problems with adulteration and poor quality have come into the focus of discussion. This has been identified in numerous countries including the USA (see below), Japan [36] and Europe [37] . Such problems are commonly linked with unregulated or poorly (self-)regulated products and very often with so-called lifestyle drugs (anti-aging, slimming, aphrodisiacs, e.g. [34] [28, 39] , the core methods required in routine quality control must be robust, fast, and highly economical (both in terms of time and equipment).
The above defines a crucial set of pharmacognostical task and while it may not be an area which results in highly influential publications, it is essential in setting industrial standards.
At the same time the fast development of ever more sensitive and advanced techniques offers [8, 9] and research is today embedded in complex regulations of best practice including the recognition of the rights of provider (countries) (Bauer et al., forthcoming). Recently, the plant derived natural products galanthamine and Peplin / ingenol-3-angelate [42] have become important new medicines. Plant derived anti-cancer agents remain core therapeutic options; e.g. [43] and numerous fungal metabolites have been developed or are under development [44] . These techniques also lead to the need for the major development of bioinformatics and related techniques. One can argue that these areas no longer should be included under the heading of pharmacognosy in a strict sense, but even then one will have to acknowledge that pharmacognosy is the origin of all these disciplines and research activities.
Conclusion
Today pharmacognosy faces numerous challenges and at the same time offers many opportunities. Identification and authentication of nature derived products have been a continuous core challenge and will remain an important competence. Clearly new methods are required for this and as such DNA-based techniques are simply an addition to the wide range of tools used in this context, and they are an exciting opportunity. Here we wanted to show the conceptual continuum and the constant incorporation of new methods into a medicalpharmaceutical science. In addition, pharmacognosy nowadays has the unique opportunity to explore further fields of investigation, especially in drug discovery and clinical development and by this return to its origins of a complex and comprehensive science for both, medicine and pharmacy.
Century-old traditions in all cultures reflect an immense knowledge of medicinal plants use which is reflected by innumerable historical sources. This fact has been commonly accepted and dealt with in many publications with comprehensive bibliography of the related essays [47] . However, many methods to explore this potential did not lead to the convincing results, especially if historical indications were directly correlated to modern applications or if the authors concentrated on a single defined species. Recent studies in history of pharmacy present methods and concepts to analyse historical traditions in detail, evaluate them according to modern scientific knowledge and link the results directly to the scientific research of the pharmaceutical branch disciplines like pharmacognosy, chemistry and pharmacology to lead to a complete drug development [48, 49, 50] .
Millennia of experience in evidence-based applications of innumerable medicinal plants used in all cultures wait to be analysed, explored and made available for modern therapy, be it as multi-compound pleiotropic preparations (herbal medical products / botanicals) or as pure natural products [2, 4] and of course based on the modern legal frameworks including the Convention on Biological Diversity [8, 42] and subsequent treaties. Already Tschirch recognized the value of historical traditions and the potential for discovering mixtures or substances with a potential for a wider use. Specifically, his concept of the synergistic efficacy of all compounds of a plant extract should be studied further in the context of understanding the implications for efficacy. While Tschirch did not have the methodological and instrumental equipment to investigate the different preparations, their respective profiles and fingerprints, their clinical efficacy and the necessary modifications and dosages, we can explore this wide and still little known field as another core competence of pharmacognosy.
The analytical power of modern hyphenated techniques and the opportunities of DNA barcoding provide great opportunities for a much better understanding of complex preparations and give a new impetus to pharmacognostic research approaches. A key challenge will be the large number of local and traditional medicines used and traded in and from biodiversity rich countries with a long and strong tradition of using herbal medicines especially from Asian countries like China, Thailand and India, but also from American and African countries. It can be predicted with certainty that this trade will continue to increase and there will be an increased need for pharmacognostical-analytical tools to assess the authenticity and quality of these products.
Pharmacognosy combines rich historical traditions and millennia of evidence-based knowledge with the expertise and skills of modern science and, therefore, is an irreplaceable and promising science for drug discovery and the development of modern drugs. In the future it may even be a new medical-pharmaceutical paradigm which could focus in multicompound mixtures as therapeutics in an adapted regulatory framework.
We would like to close with some contemplative thoughts by the famous and renowned pharmacist and pharmacognosist Franz Christian Czygan (1934 Czygan ( -2012 . In 1984, he wondered whether the exploration of medicinal plants had been neglected for such a long time that the clock already showed five after twelve. While concentrating on smallest details, we lose the view for the whole and therefore so many plants and other natural sources like marine organisms including their compounds on our planet have not been explored, which could offer an immense potential of therapeutic options. Therefore, it is our responsibility as scientists to preserve and investigate plants and further natural sources as a heritage and for the benefit of mankind [45] .
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